issue

Oct 7, 2022

Volume 18 Number 8

This issue of EuroIntervention has an ESC/EAPCI consensus paper on catheter-directed therapies for the treatment of acute pulmonary embolism as a complement to current guidelines including a review of current treatment options, standardising patient selection; a comparison of catheter-directed thrombolysis (CDT) to standard anticoagulation therapy in treating medium to high-risk acute pulmonary embolisms. In coronary interventions, a study using a pre-treatment of evolocumab in addition to statins as an adjunctive preventive therapy to prevent periprocedural microvascular dysfunction after PCI; The AVIATOR-2 international registry looking at subjective physician vs patient perception of AF-PCI antithrombotic strategies; the prognostic relevance and safety of intracoronary provocative testing with acetylcholine in INOCA and MINOCA patients. In interventions for hypertension: the 3-year results from the RADIANCE-HTN SOLO trial looking at the durability of ultrasound renal denervation in treating resistant hypertension; the measurement of arterial stiffness as a predictor of responsiveness to renal denervation and improving patient selection for RDN; and more...

Peripheral interventions - Mini focus on interventions for acute pulmonary embolism

Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions
Pruszczyk P, Klok F, Kucher N, Roik M, Meneveau N, Sharp AS, Nielsen-Kudsk J, Obradović S, Barco S, Giannini F, Stefanini G, Tarantini G, Konstantinides SV, Dudek D
10.4244/EIJ-D-22-00246
free
A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism
Kroupa J, Buk M, Weichet J, Malikova H, Bartova L, Linkova H, Ionita O, Kozel M, Motovska Z, Kocka V
10.4244/EIJ-D-21-01080
free

Coronary interventions

Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial
Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y, Mano T, Tsujita K, Igeta M, Okamoto R, Suna S
10.4244/EIJ-D-22-00269
free

Editorial comment

In search of the pleiotropic effects of PCSK9 inhibitors
Räber L, Ueki Y
10.4244/EIJ-E-22-00032
free
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Chandrasekhar J, Baber U, Sartori S, Goel R, Nicolas J, Vogel B, Snyder C, Kini A, Briguori C, Witzenbichler B, Iakovou I, Sardella G, Marzo K, DeFranco A, Stuckey T, Chieffo A, Colombo A, Shlofmitz RA, Capodanno D, Dangas G, Pocock S, Mehran R
10.4244/EIJ-D-21-01044
free
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries
Montone R, Rinaldi R, Del Buono M, Gurgoglione F, La Vecchia G, Russo M, Caffè A, Burzotta F, Leone AM, Romagnoli E, Sanna T, Pelargonio G, Trani C, Lanza GA, Niccoli G, Crea F
10.4244/EIJ-D-21-00971
free

Interventions for hypertension and stroke

Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial
Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, Levy T, Scicli A, Thackeray L, Azizi M, Weber M
10.4244/EIJ-D-22-00305
free
Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation
Fengler K, Rommel K, Kriese W, Kresoja K, Blazek S, Obradovic D, Feistritzer H, Lücke C, Gutberlet M, Desch S, Thiele H, Lurz P
10.4244/EIJ-D-21-01036
free
Percutaneous left atrial appendage closure with superior vascular access
Galea R, Roten L, Siontis G, Brugger N, Windecker S, Räber L
10.4244/EIJ-D-22-00435
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved